secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001193125-23-137079
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moderna Stockholders Elect Three Class II Directors and Approve Executive Compensation at 2023 Annual Meeting
--------------------------------------------------------------------------------

- Elected Stephen Berenson (226.6M for, 64.2M withheld), Sandra Horning (281.8M for, 8.9M withheld), and Paul Sagan (219.0M for, 71.7M withheld) as Class II directors.
- Advisory vote on named executive officer compensation approved with 254.1M for, 34.9M against, and 1.6M abstentions.
- Ratification of Ernst & Young as independent auditor for 2023 approved with 352.0M for, 3.9M against, and 0.2M abstentions.
- Shareholder proposal requesting report on feasibility of transferring intellectual property defeated: 21.4M for, 268.0M against, 1.3M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/d415922d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer